BCLAF1 and diffuse large B-cell lymphoma: Recently, Li et al. identified Bcl-2-associated transcription factor 1 (BCLAF1) as a potential epigenetic therapeutic target involved in LMK-235-mediated apoptosis in diffuse large B-cell lymphoma cells [33].